ConductScience.org, home

Paper39265169

Activating pyruvate kinase improves red blood cell integrity by reducing band 3 tyrosine phosphorylation.

Le K and 13 others. Blood Adv, 2024. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Activating pyruvate kinase improves red blood cell integrity by reducing band 3 tyrosine phosphorylation. Papers, record 39265169. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39265169

Download JSON
Disease
sickle cell disease163 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Activating pyruvate kinase improves red blood cell integrity by reducing band 3 tyrosine phosphorylation.
PubMed
Journal
Blood Adv
PubMed
Year
2024
PubMed
Publication types
Journal Article, Clinical Trial, Phase I
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
1.8, provisional
iCite
Revised in PubMed
2024-11-20
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Le KKanghttps://orcid.org/0000-0002-1714-2377
2Wang XXunde
3Chu JJonathan
4Lundt MMaureen
5Lee YYYuan Yeehttps://orcid.org/0000-0002-5938-3048
6Conrey AAnna
7Frey IIngrid
8Giannini SSilvia
9Kosinski PAPenelope A
10Hausman JMJohn Mhttps://orcid.org/0000-0002-5600-0304
11Low PSPhilip S
12Jeffries NNeal
13Desai SASanjay Ahttps://orcid.org/0000-0003-2150-2483
14Thein SLSwee Layhttps://orcid.org/0000-0002-9835-6501

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ErythrocytesMajor topic
Anion Exchange Protein 1, ErythrocyteMajor topic
Pyruvate KinaseMajor topic
Humans
Phosphorylation
Anemia, Sickle Cell
Adenosine Triphosphate
Protein Tyrosine Phosphatase, Non-Receptor Type 1
Ankyrins
Tyrosine
Enzyme Activation

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04000165A Dose-Finding Study of AG-348 in Sickle Cell DiseaseDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120455701Sickle cell biomechanics.Annu Rev Biomed Eng2010https://conductscience.org/library/papers/20455701PubMed
217576811Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets.Mol Cell Biol2007https://conductscience.org/library/papers/17576811PubMed
336512028A robust fluorescence-based assay for human erythrocyte Ca++ efflux suitable for high-throughput inhibitor screens.Eur Biophys J2023https://conductscience.org/library/papers/36512028PubMed
437934880One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study.Blood Adv2023https://conductscience.org/library/papers/37934880PubMed
55549196The effect of 2,3-DPG on the sickling phenomenon.Blood1971https://conductscience.org/library/papers/5549196PubMed
67120411Oxygen binding by sickle cell hemoglobin polymers.J Mol Biol1982https://conductscience.org/library/papers/7120411PubMed
723937112,3-Diphosphoglycerate and intracellular pH as interdependent determinants of the physiologic solubility of deoxyhemoglobin S.Blood1990https://conductscience.org/library/papers/2393711PubMed
835964609Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study.Lancet2022https://conductscience.org/library/papers/35964609PubMed
95443181Effect of 2,3-diphosphoglycerate on oxygen affinity of blood in sickle cell anemia.J Clin Invest1970https://conductscience.org/library/papers/5443181PubMed
1015866743Calcium-dependent human erythrocyte cytoskeleton stability analysis through atomic force microscopy.J Struct Biol2005https://conductscience.org/library/papers/15866743PubMed
1128248201Intravascular hemolysis and the pathophysiology of sickle cell disease.J Clin Invest2017https://conductscience.org/library/papers/28248201PubMed
1232346864Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.Br J Haematol2020https://conductscience.org/library/papers/32346864PubMed
1322197026Deoxygenation-induced and Ca(2+) dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients.Cell Calcium2012https://conductscience.org/library/papers/22197026PubMed
149109401Erythrocyte thiol status regulates band 3 phosphotyrosine level via oxidation/reduction of band 3-associated phosphotyrosine phosphatase.FEBS Lett1997https://conductscience.org/library/papers/9109401PubMed
158223493Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets.EMBO J1993https://conductscience.org/library/papers/8223493PubMed
1611698299Deoxygenation of sickle cells stimulates Syk tyrosine kinase and inhibits a membrane tyrosine phosphatase.Blood2001https://conductscience.org/library/papers/11698299PubMed
1735576529A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease.Blood2022https://conductscience.org/library/papers/35576529PubMed
189491367The structure and function of band 3 (AE1): recent developments (review).Mol Membr Biol1997https://conductscience.org/library/papers/9491367PubMed
1917138828The effect of deoxygenation on whole-cell conductance of red blood cells from healthy individuals and patients with sickle cell disease.Blood2007https://conductscience.org/library/papers/17138828PubMed
2014717789Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells.Br J Haematol2004https://conductscience.org/library/papers/14717789PubMed

See all 38 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42348606A high-throughput inhibitor screen for the erythrocyte plasma membrane Ca++ ATPase.PLoS One2026https://conductscience.org/library/papers/42348606PubMed
41978829Post-translational Modifications in Proteins: Prediction Methods, Biological Functions, and Diseases.MedComm (2020)2026https://conductscience.org/library/papers/41978829PubMed
41809202Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease.Blood Red Cells Iron2025https://conductscience.org/library/papers/41809202PubMed
41557517Pyruvate kinase deficiency modifies sickle hemoglobin carrier and sickle cell disease phenotypes in mice.JCI Insight2026https://conductscience.org/library/papers/41557517PubMed
40829689SIRPα extracellular domain shed from neutrophils by ADAM10 aggravates sepsis via initiating nitric oxide release from erythrocyte.J Adv Res2026https://conductscience.org/library/papers/40829689PubMed
39769244Epicatechin Influence on Biochemical Modification of Human Erythrocyte Metabolism and Membrane Integrity.Int J Mol Sci2024https://conductscience.org/library/papers/39769244PubMed
38118071Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease.Blood2024https://conductscience.org/library/papers/38118071PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANK1286PubTator's text mininghttps://conductscience.org/library/genes/286NCBI Gene
PTPN15770PubTator's text mininghttps://conductscience.org/library/genes/5770NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
MITAPIVATCHEMBL4299940Derived from the trial1https://conductscience.org/library/drugs/CHEMBL4299940

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39265169

GET https://conductscience.org/api/papers/v1/39265169/references?page=2